Literature DB >> 127017

The requirement for DNA synthesis and gene expression in the generation of cytotoxicity in vitro.

J Nedrud, M Touton, W R Clark.   

Abstract

The requirement for cell division and expression of new genes was examined in the primary and secondary mouse mixed leukocyte culture (MLC). Hydroxyurea (HU) was used to block DNA synthesis and cell division, and 5-bromo-2'-deoxyuridine (BUdR) was used to probe for the expression of new cell-specific genes. In the primary MLC, inhibition of DNA synthesis and cell division by HU almost totally suppressed the generation of initial, target-specific cytotoxicity. When HU was washed out of the cultures, cytotoxicity was generated after a lag time approximately equal to the period of treatment with HU. The rate of development and maximal value of cytotoxicity in HU-reversed cultures was identical to untreated controls, suggesting that the inhibition was not due to a nonspecific lethal effect of the drug. Development of initial cytotoxicity in primary MLC was similarly suppressed by levels of BUdR 25 to 75-fold below the levels of this drug having nonspecific mutagenic effects in lymphocytes, indicating that development of cytotoxicity was also dependent on the expression of a new genetic program. In the secondary MLC, regeneration of both DNA synthesis and cytotoxicity was apparent 12-15 h after re-exposure to initial stimulating antigen. In this reaction, however, generation of cytotoxicity was insensitive to both HU and BUdR. Thus, the cytotoxic program developed in the primary MLC appears to be genetically stable through the production of effector memory cells, and into regeneration of fully cytotoxic memory cells in secondary MLC.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 127017      PMCID: PMC2189954          DOI: 10.1084/jem.142.4.960

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  An antigen-specific component of lectin-mediated cytotoxicity.

Authors:  W R Clark
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

Review 2.  Toward molecular mechanisms of developmental processes.

Authors:  W J Rutter; R L Pictet; P W Morris
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

3.  Histocompatibility antigens causing stimulation in mixed lymphocyte culture interactions. Antigenic identity or similarity between individuals.

Authors:  H Hirschberg; E Thorsby
Journal:  Transplantation       Date:  1973-11       Impact factor: 4.939

4.  Specific priming of mouse thymus-dependent lymphocytes to allogeneic cells in vitro.

Authors:  L C Andersson; P Häyry
Journal:  Eur J Immunol       Date:  1973-09       Impact factor: 5.532

5.  Effect of BUdR on proliferation and development of cytotoxicity in mixed leukocyte culture.

Authors:  W Clark; J Nedrud
Journal:  Cell Immunol       Date:  1974-01       Impact factor: 4.868

6.  Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.

Authors:  J D Waterfield; E M Waterfield; G Möller
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

Review 7.  Surface reorganization as initial inductive event in the differentiation of prothymocytes to thymocytes.

Authors:  E A Boyse; J Abbott
Journal:  Fed Proc       Date:  1975-01

8.  Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.

Authors:  M Howe; L Berman; L Cohen
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

9.  Lac operator analogues: bromodeoxyuridine substitution in the lac operator affects the rate of dissociation of the lac repressor.

Authors:  S Y Lin; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  9 in total

1.  The requirement for the expression of previously unexpressed genes in the generation of T and B antigen-binding cells and the changes in sIg isotype following in vitro immunization.

Authors:  J E Merrill; R F Ashman
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

2.  Cell division and deoxyribonucleic acid (DNA) synthesis in cultures of stimulated lymphocytes.

Authors:  G Harris; I Olsen
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

3.  A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.

Authors:  O Marker; G T Andersen
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

4.  Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle.

Authors:  M Sarzotti; S Landolfo; F Dianzani
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

5.  Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.

Authors:  K F Lindahl; D B Wilson
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

6.  Lectin-driven maturation of cytotoxic effector cells: the nature of effector memory.

Authors:  A K Chakravarty; W R Clark
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

7.  Primary generation of cytolytic T lymphocytes in the absence of DNA synthesis.

Authors:  H R MacDonald; R K Less
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

8.  Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes.

Authors:  A Senik; B R Bloom
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required.

Authors:  P H Bick; G Möller
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.